ORIC Pharmaceuticals Inc. (ORIC)

7.66

-0.37 (-4.61%)

At close: Mar 03, 2025, 3:59 PM

7.64

-0.26%

After-hours: Mar 03, 2025, 04:00 PM EST

ORIC Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-127.85M	-100.7M	-89.12M	-78.72M	-73.7M	-26.88M	-21.36M	-22.03M
Depreciation & Amortization	1.11M	1.03M	966K	897K	970K	1.03M	903K	900K
Stock-Based Compensation	20.21M	15.23M	14.46M	12.85M	5.28M	1.09M	469K	217.00
Other Working Capital	143K	1.62M	1.03M	1.14M	-2.26M	234K	-297K	89K
Other Non-Cash Items	-8.1M	-6.15M	-1M	1.35M	19.84M	8K	15K	2M
Deferred Income Tax	n/a	n/a	n/a	n/a	299K	n/a	n/a	n/a
Change in Working Capital	1.97M	4.9M	-445K	4.07M	2.04M	1.22M	-707K	95K
Operating Cash Flow	-112.66M	-85.69M	-75.14M	-59.54M	-45.27M	-23.53M	-20.68M	-20.83M
Capital Expenditures	n/a	-849K	-2.08M	-939K	-667K	-768K	-525K	-486K
Acquisitions	n/a	n/a	2.08M	1.38M	n/a	n/a	n/a	n/a
Purchase of Investments	-251.92M	-239.24M	-238.12M	-69.63M	-225.49M	n/a	n/a	n/a
Sales Maturities Of Investments	275.25M	196.69M	130.95M	229M	10M	n/a	n/a	n/a
Other Investing Acitivies	-1.19M	n/a	-2.08M	-1.38M	193K	n/a	17K	194K
Investing Cash Flow	22.14M	-43.4M	-109.25M	158.44M	-215.96M	-768K	-508K	-292K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.55M	1.54M	225K	-866K	-20.79M	70.82M	38.01M	n/a
Financial Cash Flow	126.55M	85.66M	25.62M	49.13M	250.51M	70.82M	38.01M	260K
Net Cash Flow	36.02M	-43.43M	-159.17M	148.03M	-10.71M	46.52M	16.82M	-20.86M
Free Cash Flow	-112.66M	-86.54M	-77.22M	-60.48M	-45.94M	-24.3M	-21.21M	-21.32M